2–4 Jun 2010
CERN
Europe/Zurich timezone
<span style="color:red"> "Deadline for Proceedings contributions: 20 July 2010" </span>

Session

Session 5 - Medical & industrial accelerators

3 Jun 2010, 14:50
6-2-024 (BE Auditorium Meyrin) (CERN)

6-2-024 (BE Auditorium Meyrin)

CERN

Geneva 23 CH-1211 Geneva Switzerland

Conveners

Session 5 - Medical & industrial accelerators

  • Marco Silari (CERN)

Presentation materials

There are no materials yet.

  1. Georg Fehrenbacher (GSI)
    03/06/2010, 14:50
    Medical and industrial accelerators
    During last years the construction of clinical proton and ion accelerators for applications in tumour therapy makes great strides. Based on encouraging results for tumour treatments in particle therapy in the past more and more facilities are presently installed worldwide. Due an enumeration of particle therapy facilities given by the PTCOG (Particle Therapy Cooperative Group) 44 facilities...
    Go to contribution page
  2. Prof. Reinhold G. Mueller (Univ. Erlangen DGMP; AAPM; DEGRO)
    03/06/2010, 15:20
    Medical and industrial accelerators
    The construction company of Forster Ingenieurgesellschaft mbH has developed in cooperation with the University Erlangen-Nuremberg a process for the erection of radiation-shielded structures utilizing precast concrete components. About 50 bunkers were constructed using this sandwich technology during last three years. The core of the buildings is the filling material in-between the outer and...
    Go to contribution page
  3. Wolfgang Dittrich (AREVA NP GmbH)
    03/06/2010, 15:40
    Medical and industrial accelerators
    The German publicly available specification PAS1078 from Jan. 2008 provides rules for the construction of structural radiation protection in the case of medical accelerator facilities for proton therapy. The major points of PAS 1078 will be presented. Its methods for the estimation of shielding thicknesses will be compared with the results of Monte-Carlo calculations executed with MCNPX....
    Go to contribution page
  4. Dr Frederic Stichelbaut (Ion Beam Applications)
    03/06/2010, 16:30
    Medical and industrial accelerators
    The IBA Company is the industry leader in proton therapy (PT) technology with seven PT centers treating patients every day in the USA and Asia and nine additional centers in construction and installation in the USA and in Europe. IBA now develops a hadron therapy system that is complementary to its proton therapy systems. It is based on a K=1600 superconducting cyclotron delivering 400...
    Go to contribution page
  5. Dr Koji Oishi (Institute of Technology, Shimizu Corporation)
    03/06/2010, 16:50
    Medical and industrial accelerators
    Recently electric linac oncology facilities incorporating seismic base-isolation structure have become very popular in Japan to prevent strong impact to the equipments by the earthquakes. When the boundary of the registered area is set below the base-isolated foundations, additional shielding of iron plate is needed and the cost for shielding increases up to $100M. Since no one usually...
    Go to contribution page
  6. Mr Mauricio Garcia (UNED)
    03/06/2010, 17:10
    Medical and industrial accelerators
    IFMIF will be an accelerator-based neutron source to test candidate materials for nuclear fusion reactors. During the Engineering Validation and Design Activities (EVEDA) phase, a prototype accelerator (125 mA CW 9 MeV deuterons) will be tested in Rokkasho (Japan). As no target is foreseen for the accelerated beam during this phase, a beam dump is required to stop it during commissioning and...
    Go to contribution page
  7. 03/06/2010, 17:30
Building timetable...